News

From 27 to 29 March 2026, MU–Varna organises the 6th International Symposium on Adipobiology and Adipopharmacology—a scientific forum bringing together leading researchers from Europe, Asia, and America working in the fields of metabolic diseases, adipose tissue biology, and modern therapeutic approaches to obesity.The Symposium aims to promote international scientific exchange and collaboration in the study of metabolic diseases—one of the most serious challenges facing contemporary public heal...

The video on the topic is available her​e.The Neurosurgery Clinic at UMHAT “St. Marina" – Varna has expanded its high-tech capacity with the introduction of a state-of-the-art surgical microscope. The equipment was delivered under the Recovery and Resilience Mechanism, aimed at modernising paediatric healthcare facilities and improving child health services.“The new microscope provides excellent visualisation, enabling maximum precision and minimally invasive access to the extremely delicate bra...

The ENT (Ear, Nose and Throat) Clinic at UMHAT “St. Marina" – Varna can boast new high-tech endoscopic surgical equipment, significantly expanding the possibilities for diagnosing and treating diseases of the ear, nose, and throat. The technology provides crystal-clear imaging and high magnification, enabling highly precise surgical procedures, including in areas close to vital structures such as the eyes and the base of the skull. The main benefits for patients include minimal trauma, increased...

The first course in Medical Communications was successfully completed, with 28 specialists and lecturers from MU–Varna and UMHAT “St. Marina" receiving certification.  The intensive course, entitled “Improving Communication with Patients and Learners", was held from 13 to 15 March 2026, at the Clinic of Psychiatry at UMHAT “St. Marina" – Varna. The training, attended by physicians, healthcare professionals, and lecturers, was organized by the Centre for Medical Pedagogy and Communications at Med...

An international research team from Mannheim, Göttingen, Varna, and Princeton, with participation from MU–Varna, has demonstrated that the growth factor recombinant human erythropoietin (rhEPO) can significantly improve cognitive and social impairments in Primrose syndrome—a rare and severe genetic disorder caused by reduced levels of the ZBTB20 gene. The results were published in the prestigious scientific journal Journal of Clinical Investigation Insight, and provide the first evidence that er...